JenaValve Amasankha Kari Moore ngati Chief Financial Officer

IRVINE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. ("JenaValve kapena "Company"), wopanga ndi kupanga makina osiyanitsa a transcatheter aortic valve replacement (TAVR), lero alengeza kukhazikitsidwa kwa Kari Moore monga Chief Financial Officer wa kampaniyi kuyambira Meyi 10, 2022. "Ndife okondwa kulandira Kari ku gulu la JenaValve," atero CEO wa JenaValve John Kilcoyne." Kari ali ndi zaka zopitilira 35 akudziwa zambiri pazachuma komanso magwiridwe antchito pazida zamankhwala ndipo mafakitale azaumoyo. Kudziwa zambiri za Kari komanso ukadaulo wamakampani zitithandiza kupitilizabe kugwiritsa ntchito njira zathu zamankhwala ndikupititsa patsogolo Trilogy yathu pochiza matenda a aortic valve ® Kuyesetsa Kugulitsa kwa Heart Valve Systems. Mayi Moore alowa nawo JenaValve atagwira ntchito ngati Chief Accounting Officer wa Envista Holdings Corporation, kampani yapadziko lonse yamakampani opanga mano, komwe anali ndi udindo wowerengera ndalama padziko lonse lapansi, zachuma ndi ntchito zogawana ntchito. Asanalowe Envista Holdings Corporation, Mayi Moore anali Chief Accounting Officer wa Applied Medical Corporation, kampani yapadziko lonse ya zipangizo zachipatala yopereka matekinoloje ndi njira zothetsera opaleshoni yocheperako komanso yamba. Moore anayamba ntchito zake ku PricewaterhouseCoopers, komwe ankagwira ntchito yowerengera ndalama, makamaka pa ntchito ya sayansi ya moyo. Pa zaka 20 za ntchito yake, Mayi Moore adatengera makampani ambiri poyera ndikuwathandiza pogula, kuchotseratu komanso kupereka ngongole. BA mu Business Administration kuchokera ku University of Southern California ndipo ndi CPA m'chigawo cha California. "Ndili wokondwa kujowina JenaValve panthawi yovuta kwambiri," adatero Ms. Moore. "Ndili wokondwa kugwira ntchito ndi gulu lonse la JenaValve pamene tikupitirizabe kukula ndi njira zopangira phindu pamene tikupititsa patsogolo miyoyo ya odwala." About JenaValve JenaValve Technology, Inc., yomwe ili ku Irvine, California, yomwe ili ndi malo ku Leeds, UK ndi Munich, Germany, imapanga ndi kupanga transcatheter aortic valve replacement (TAVR) zothandizira odwala omwe ali ndi matenda a aortic valve.JenaValve amathandizidwa ndi Bain Capital Life Sciences ndi Cormorant Asset Management, komanso osunga ndalama aku Europe ndi Asia kuphatikiza Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners ndi Peijia Medical Limited (HKEx: 9996) . United States: Chisamaliro - Zida Zofufuza.Zoletsedwa ndi malamulo a federal (kapena US) kuti agwiritse ntchito kafukufuku wokha.